Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma

(1) Background: Many transporters of the SLC22 family (e.g., OAT1, OAT3, OCT2, URAT1, and OCTN2) are highly expressed in the kidney. They transport drugs, metabolites, signaling molecules, antioxidants, nutrients, and gut microbiome products. According to the Remote Sensing and Signaling Theory, SLC...

Full description

Bibliographic Details
Main Authors: Thomas C. Whisenant, Sanjay K. Nigam
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/19/4772
_version_ 1797480204168331264
author Thomas C. Whisenant
Sanjay K. Nigam
author_facet Thomas C. Whisenant
Sanjay K. Nigam
author_sort Thomas C. Whisenant
collection DOAJ
description (1) Background: Many transporters of the SLC22 family (e.g., OAT1, OAT3, OCT2, URAT1, and OCTN2) are highly expressed in the kidney. They transport drugs, metabolites, signaling molecules, antioxidants, nutrients, and gut microbiome products. According to the Remote Sensing and Signaling Theory, SLC22 transporters play a critical role in small molecule communication between organelles, cells and organs as well as between the body and the gut microbiome. This raises the question about the potential role of SLC22 transporters in cancer biology and treatment. (2) Results: In two renal cell carcinoma RNA-seq datasets found in TCGA, KIRC and KIRP, there were multiple differentially expressed (DE) SLC22 transporter genes compared to normal kidney. These included SLC22A6, SLC22A7, SLC22A8, SLC22A12, and SLC22A13. The patients with disease had an association between overall survival and expression for most of these DE genes. In KIRC, the stratification of patient data by pathological tumor characteristics revealed the importance of SLC22A2, SLC22A6, and SLC22A12 in disease progression. Interaction networks combining the SLC22 with ADME genes supported the centrality of SLC22 transporters and other transporters (ABCG2, SLC47A1) in disease progression. (3) Implications: The fact that many of these genes are uric acid transporters is interesting because altered uric acid levels have been associated with kidney cancer. Moreover, these genes play key roles in processing metabolites and chemotherapeutic compounds, thus making them potential therapeutic targets. Finally, our analyses raise the possibility that current approaches may undertreat certain kidney cancer patients with low SLC22 expression and only localized disease while possibly overtreating more advanced disease in patients with higher SLC22 expression. Clinical studies are needed to investigate these possibilities.
first_indexed 2024-03-09T21:56:43Z
format Article
id doaj.art-661a533816e14dba918a74f750cb74ff
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T21:56:43Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-661a533816e14dba918a74f750cb74ff2023-11-23T19:56:21ZengMDPI AGCancers2072-66942022-09-011419477210.3390/cancers14194772Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell CarcinomaThomas C. Whisenant0Sanjay K. Nigam1Center for Computational Biology and Bioinformatics, University of California, San Diego, CA 92093-0693, USADepartment of Pediatrics, University of California, San Diego, CA 92093-0693, USA(1) Background: Many transporters of the SLC22 family (e.g., OAT1, OAT3, OCT2, URAT1, and OCTN2) are highly expressed in the kidney. They transport drugs, metabolites, signaling molecules, antioxidants, nutrients, and gut microbiome products. According to the Remote Sensing and Signaling Theory, SLC22 transporters play a critical role in small molecule communication between organelles, cells and organs as well as between the body and the gut microbiome. This raises the question about the potential role of SLC22 transporters in cancer biology and treatment. (2) Results: In two renal cell carcinoma RNA-seq datasets found in TCGA, KIRC and KIRP, there were multiple differentially expressed (DE) SLC22 transporter genes compared to normal kidney. These included SLC22A6, SLC22A7, SLC22A8, SLC22A12, and SLC22A13. The patients with disease had an association between overall survival and expression for most of these DE genes. In KIRC, the stratification of patient data by pathological tumor characteristics revealed the importance of SLC22A2, SLC22A6, and SLC22A12 in disease progression. Interaction networks combining the SLC22 with ADME genes supported the centrality of SLC22 transporters and other transporters (ABCG2, SLC47A1) in disease progression. (3) Implications: The fact that many of these genes are uric acid transporters is interesting because altered uric acid levels have been associated with kidney cancer. Moreover, these genes play key roles in processing metabolites and chemotherapeutic compounds, thus making them potential therapeutic targets. Finally, our analyses raise the possibility that current approaches may undertreat certain kidney cancer patients with low SLC22 expression and only localized disease while possibly overtreating more advanced disease in patients with higher SLC22 expression. Clinical studies are needed to investigate these possibilities.https://www.mdpi.com/2072-6694/14/19/4772kidney cancerremote sensing and signalingSLC22KIRCKIRPSLC22A1
spellingShingle Thomas C. Whisenant
Sanjay K. Nigam
Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
Cancers
kidney cancer
remote sensing and signaling
SLC22
KIRC
KIRP
SLC22A1
title Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
title_full Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
title_fullStr Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
title_full_unstemmed Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
title_short Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
title_sort organic anion transporters oat and other slc22 transporters in progression of renal cell carcinoma
topic kidney cancer
remote sensing and signaling
SLC22
KIRC
KIRP
SLC22A1
url https://www.mdpi.com/2072-6694/14/19/4772
work_keys_str_mv AT thomascwhisenant organicaniontransportersoatandotherslc22transportersinprogressionofrenalcellcarcinoma
AT sanjayknigam organicaniontransportersoatandotherslc22transportersinprogressionofrenalcellcarcinoma